Home Health and Hospice Mergers and Acquisitions: A Post Pandemic Market Gone Viral is proudly presented to you by National Association for Home Care & Hospice. Thank you. We hope that you enjoy your course.
Description:
Who knew that when we last gathered in October 2019 discussing home health and hospice mergers and acquisitions that we were just a few months away from one of those “assuming nothing out of the ordinary” qualifiers actually upending the market as we knew it? A pandemic, three vaccines, a new administration, and trillions of dollars of new federal spending later, where is the market today, and where is it heading? Why did hospice valuations rise to unprecedented levels, and what could rein them in? How did PDGM part one and part deux impact home health deal flow, and what can we expect heading into 2022? How will strains on state budgets impact Medicaid reimbursement and eligibility? What impact will PTSD born shortages of nurse staffing have on providers? Are the reasons driving consolidation pre-COVID still relevant? In this session, we will break it all down, and what it means for buyers, sellers, acquisition supply, demand, and ultimately, valuation.
Learning Objectives:
- Cite how the pandemic impacted deal flow across home health, hospice, state funded, and private pay sectors, especially as it relates to private equity sponsors that often drive these markets.
- Identify the health care policy, economic, strategic, and other market conditions that are likely to shape the home health and hospice M&A market over the next 6-18 months.
- Explain how the interplay of the variety of factors impacting the market may impact consolidation strategies, market timing, and valuation.
Faculty:
Dexter Braff, MBA, MS
Mark Kulik, MAMI